Treatment patterns and costs of care for patients with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin in the United States: A retrospective cohort study.

Saved in:
Bibliographic Details
Title: Treatment patterns and costs of care for patients with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin in the United States: A retrospective cohort study.
Authors: Szabo, Shelagh M.1 sszabo@broadstreetheor.com, Hirji, Ishan2, Johnston, Karissa M.1, Juarez-Garcia, Ariadna2, Connors, Joseph M.3
Source: PLoS ONE. 10/09/2017, Vol. 12 Issue 10, p1-16. 16p.
Database: Academic Search Ultimate
Description
ISSN:19326203
DOI:10.1371/journal.pone.0180261